Products

What will AGI do for Ambenonium?

This classification denotes an acetylcholinesterase inhibitor with the molecular formula C28H42Cl2N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L16PUN799N, chemically known as benzenemethanaminium, n,n-((1,2-dioxo-1,2-ethanediyl)bis(imino-2,1-ethanediyl))bis(2-chloro-n,n-diethyl- but generally known as ambenonium, which bears US NIH Compound Identifier 2131. Ambenonium most often comes in base, chloride, and dichloride forms. European Medicines Agency schedules Ambenonium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00425MIG. World Health Organization schedules ambenonium in its Anatomical Therapeutic Chemical (ATC) Classification. AMBENONIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, AMBENONIUM remains the US FDA Preferred Term for this commodity. Ambenonium bears US NLM identifiers UMLS ID C0002412 and NCI Concept Code C76136. SMILES: CLC1C(C[N](CCNC(=O)C(=O)NCC[N](CC2C(CL)CCCC2)(CC)CC)(CC)CC)CCCC1.